IMMUNITYBIO, INC. Interest Payable
IMMUNITYBIO, INC. (IBRX) had Interest Payable of $31.71 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2023-05-11
- 2023-03-31: Interest Payable $31.71M.
- 2022-12-31: Interest Payable $29.15M.
- 2022-09-30: Interest Payable $39.09M.
- 2022-03-31: Interest Payable $32.80M.
| Period end | Interest Payable | Interest Payable as first filed |
|---|---|---|
| 2023-03-31 | $31.71M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $29.15M 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $39.09M 10-Q · filed 2022-11-09 | |
| 2022-03-31 | $32.80M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $30.38M 10-K · filed 2023-03-01 | $29.70M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |